Search results
Results from the WOW.Com Content Network
COVID-19 pandemic in Russia: Target: Immunization against COVID-19: Participants: 81,580,140 people have received at least one dose (21 June 2022) [3] 74,311,072 people have been fully vaccinated (21 June 2022) [3] Outcome: 55.86% of the Russian population has received at least one dose of a vaccine [a] [3] [4] 50.88% of the Russian population ...
The COVID-19 pandemic in Estonia was a part of the worldwide pandemic of coronavirus disease 2019 (COVID-19) caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). The virus was confirmed to have spread to Estonia when the first case was confirmed in Tallinn on 27 February 2020. [ 3 ]
A real-world study with participants aged 60–79 years in Argentina found that the single-injection vaccine is 79% (95% CI, 75 – 82%) effective in preventing infections, 88% (95% CI, 80 – 92%) effective against hospitalization, and 85% (95% CI, 75 – 91%) against death. [8] A phase III clinical trial in Russia also found an efficacy of 79%.
During the coronavirus pandemic, Russia developed its own Sputnik V vaccine against COVID-19 and sold it to a number of countries, although domestically it ran up against widespread public ...
A large-scale study in Buenos Aires from December 29, 2020, to May 15, 2021, with 663,602 participants aged 60 and older who received Spunik V, the Oxford–AstraZeneca vaccine, or the Sinopharm BIBP vaccine observed an overall efficacy of 98% (95% CI, 95 – 99%) against COVID-19-related deaths. The study noted that the three vaccines showed a ...
Yahoo News has obtained confidential strategy documents drawn up by the Kremlin that reveal Russia’s ambitious plans to exert its influence in the Baltic states of Estonia, Latvia and Lithuania.
Russian neighbour Estonia has no "demands" for NATO allies to increase their troop presence there, Prime Minister Kaja Kallas said on Wednesday, after Germany and Canada outlined plans to deploy ...
CoviVac (Russian: КовиВак) is an inactivated virus-based COVID-19 vaccine developed by the Chumakov Centre , [2] which is an institute of the Russian Academy of Sciences. [3] It was approved for use in Russia in February 2021, being the third COVID-19 vaccine to get approval in Russia. [ 2 ]